From 2013 to 2023, UK pharmaceutical exports have seen significant fluctuations. They grew modestly from 2013 to 2015, with annual growth peaking at 6.65% in 2015. However, from 2016, exports witnessed a general decline, exacerbated by a significant drop in 2019 (-14.32%) and continuing to 2023, when exports stood at 23.13 billion USD, showing a further year-on-year decline of 6.21%.
The last two years exhibited notable volatility, with 2022 seeing a 10.36% decrease, followed by a 6.21% decrease in 2023. The Compound Annual Growth Rate (CAGR) from 2019 to 2023 was -6.96%, reflecting a sustained downward trend in exports.
Forecasted data from 2024 to 2028 indicate continued contraction, with exports predicted to decline to 15.7 billion USD by 2028, marking an average annual decrease of 6.19%, and a total decrease of 27.34% over the five-year period.
Future trends to watch for:
- External pressures like regulatory changes post-Brexit.
- Shifts in global market demand influenced by emerging market dynamics.
- Innovations in pharmaceutical technology and production efficiency.
